CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Oral Anticoagulants in Non-valvular Atrial Fibrillation: CADTH Recommendations and Clinical Practice Guidelines

Last Updated: February 8, 2016
Result type: Tools

This tool explains the key differences between CADTH recommendations and clinical practice guidelines on the use of oral anticoagulants in non-valvular atrial fibrillation.